mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.9 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.051 |
0.9 |